In an attempt to improve specific biological functions of cytokinins routinely used in plant micropropagation, 33 6-benzylamino-9-tetrahydropyran-2-ylpurine (THPP) and 9-tetrahydrofuran-2-ylpurine (THFP) derivatives, with variously positioned hydroxy and methoxy functional groups on the benzyl ring, were prepared. The new derivatives were prepared by condensation of 6-chloropurine with 3,4-dihydro-2H-pyran or 2,3-dihydrofuran and then by the condensation of these intermediates with the corresponding benzylamines. The prepared compounds were characterized by elemental analyses, TLC, HPLC, melting point determinations, CI+ MS and (1)H NMR spectroscopy. The cytokinin activity of all the prepared derivatives was assessed in three classical cytokinin bioassays (tobacco callus, wheat leaf senescence and Amaranthus bioassay). The derivatives 6-(3-hydroxybenzylamino)-9-tetrahydropyran-2-ylpurine (3) and 6-(3-hydroxybenzylamino)-9-tetrahydrofuran-2-ylpurine (23) were selected, because of the high affinity of their parent compound meta-topolin (mT, 6-(3-hydroxybenzylamino)purine) to cytokinin receptors, as model compounds for studying their perception by the receptors CRE1/AHK4 and AHK3 in a bacterial assay. Both receptors perceived these two derivatives less well than they perceived the parent compound. Subsequently, the susceptibility of several new derivatives to enzyme degradation by cytokinin oxidase/dehydrogenase was studied. Substitution of tetrahydropyran-2-yl (THP) at the N(9) position decreased the turnover rates of all new derivatives to some extent. To provide a practical perspective, the cytotoxicity of the prepared compounds against human diploid fibroblasts (BJ) and the human cancer cell lines K-562 and MCF-7 was also assayed in vitro. The prepared compounds showed none or marginal cytotoxicity compared to the corresponding N(9)-ribosides. Finally, the pH stability of the two model compounds was assessed in acidic and neutral water solutions (pH 3-7) by high-performance liquid chromatography (HPLC).

Laboratory of Growth Regulators Palacky University and Institute of Experimental Botany AS CR Olomouc Czech Republic

000      

04088naa 2200541 a 4500

001      

bmc11009579

003      

CZ-PrNML

005      

20121114125647.0

008      

110510s2009 xxk e eng||

009      

AR

040    __

$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxk

100    1_

$a Plíhalová, Lucie $7 xx0110494

245    10

$a Synthesis, characterization and biological activity of ring-substituted 6-benzylamino-9-tetrahydropyran-2-yl and 9-tetrahydrofuran-2-ylpurine derivatives / $c L. Szüčová, L. Spichal, K. Doležal, M. Zatloukal, J. Greplová, P. Galuszka, V. Kryštof, J. Voller, I. Popa, F.J. Massino, J.E. Jorgensen, M. Strnad

314    __

$a Laboratory of Growth Regulators, Palacky University & Institute of Experimental Botany AS CR, Olomouc, Czech Republic. lucie.szucova@upol.cz

520    9_

$a In an attempt to improve specific biological functions of cytokinins routinely used in plant micropropagation, 33 6-benzylamino-9-tetrahydropyran-2-ylpurine (THPP) and 9-tetrahydrofuran-2-ylpurine (THFP) derivatives, with variously positioned hydroxy and methoxy functional groups on the benzyl ring, were prepared. The new derivatives were prepared by condensation of 6-chloropurine with 3,4-dihydro-2H-pyran or 2,3-dihydrofuran and then by the condensation of these intermediates with the corresponding benzylamines. The prepared compounds were characterized by elemental analyses, TLC, HPLC, melting point determinations, CI+ MS and (1)H NMR spectroscopy. The cytokinin activity of all the prepared derivatives was assessed in three classical cytokinin bioassays (tobacco callus, wheat leaf senescence and Amaranthus bioassay). The derivatives 6-(3-hydroxybenzylamino)-9-tetrahydropyran-2-ylpurine (3) and 6-(3-hydroxybenzylamino)-9-tetrahydrofuran-2-ylpurine (23) were selected, because of the high affinity of their parent compound meta-topolin (mT, 6-(3-hydroxybenzylamino)purine) to cytokinin receptors, as model compounds for studying their perception by the receptors CRE1/AHK4 and AHK3 in a bacterial assay. Both receptors perceived these two derivatives less well than they perceived the parent compound. Subsequently, the susceptibility of several new derivatives to enzyme degradation by cytokinin oxidase/dehydrogenase was studied. Substitution of tetrahydropyran-2-yl (THP) at the N(9) position decreased the turnover rates of all new derivatives to some extent. To provide a practical perspective, the cytotoxicity of the prepared compounds against human diploid fibroblasts (BJ) and the human cancer cell lines K-562 and MCF-7 was also assayed in vitro. The prepared compounds showed none or marginal cytotoxicity compared to the corresponding N(9)-ribosides. Finally, the pH stability of the two model compounds was assessed in acidic and neutral water solutions (pH 3-7) by high-performance liquid chromatography (HPLC).

590    __

$a bohemika - dle Pubmed

650    _2

$a nádorové buněčné linie $7 D045744

650    _2

$a cytokininy $x chemie $x metabolismus $7 D003583

650    _2

$a stabilita léku $7 D004355

650    _2

$a fibroblasty $x účinky léků $7 D005347

650    _2

$a furany $x chemická syntéza $x chemie $x toxicita $7 D005663

650    _2

$a lidé $7 D006801

650    _2

$a koncentrace vodíkových iontů $7 D006863

650    _2

$a kinetika $7 D007700

650    _2

$a puriny $x chemická syntéza $x chemie $x toxicita $7 D011687

650    _2

$a pyrany $x chemická syntéza $x chemie $x toxicita $7 D011714

650    _2

$a financování organizované $7 D005381

700    1_

$a Spíchal, Lukáš $7 xx0123817

700    1_

$a Doležal, Karel, $d 1967- $7 xx0100056

700    1_

$a Zatloukal, Marek $7 xx0113001

700    1_

$a Greplová, Jarmila. $7 _AN063082

700    1_

$a Galuszka, Petr, $d 1974- $7 jo20000082919

700    1_

$a Kryštof, Vladimír, $d 1973- $7 xx0097406

700    1_

$a Voller, Jiří. $7 _AN043406

700    1_

$a Popa, Igor $7 jo2012690165

700    1_

$a Massino, Frank J.

700    1_

$a Jorgensen, Jan-Elo

700    1_

$a Strnad, Miroslav, $d 1958- $7 jn20010309068

773    0_

$t Bioorganic & Medicinal Chemistry $w MED00000769 $g Roč. 17, č. 5 (2009), s. 1938-1947

910    __

$a ABA008 $b x $y 2

990    __

$a 20110513110534 $b ABA008

991    __

$a 20121114125703 $b ABA008

999    __

$a ok $b bmc $g 839103 $s 702968

BAS    __

$a 3

BMC    __

$a 2009 $b 17 $c 5 $d 1938-1947 $m Bioorganic & medicinal chemistry $n Bioorg Med Chem $x MED00000769

LZP    __

$a 2011-2B09/jvme